CIAM
INKT icon

Caitong International Asset Management’s MiNK Therapeutics INKT Stock Holding History

Caitong International Asset Management’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210 Buy
18
+8
+80% +$93 ﹤0.01% 1993
2026
Q1 		$105 Buy
+10
New +$111 ﹤0.01% 1961

Other funds holding INKT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Caitong International Asset Management's INKT Position: Q2 2026 in Review

Caitong International Asset Management increased its MiNK Therapeutics (INKT) stake by 80% in Q2 2026, buying an estimated $93 and bringing the position to 18 shares worth $210. The position accounts for ﹤0.01% of the portfolio, ranked #1993.

Caitong International Asset Management first reported a position in INKT in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold INKT as of Q2 2026.

  • Caitong International Asset Management held 18 shares of MiNK Therapeutics worth $210 as of Q2 2026.
  • Caitong International Asset Management bought 8 MiNK Therapeutics shares in Q2 2026, an estimated $93.
  • MiNK Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1993 holding.
  • Caitong International Asset Management first reported a position in MiNK Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.